TC BioPharm (Holdings) plc received a written notification from Nasdaq stating that its minimum closing bid price per share for its American Depositary Shares (ADSs) was below $1.00 for 30 consecutive business days, but regained compliance with the minimum bid price requirement after the closing bid price per share of the Company's ADSs was at least $1.00 for 10 consecutive business days.